Skip to content

Clinical trials

Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in China with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Status: Unknown status Country / region: China Clear all

73 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20121
20136
20141
20153
201615
20175
20183
20199
20208
20217
20227
20234
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status73

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Nanfang Hospital, Southern Medical University6
PersonGen BioTherapeutics (Suzhou) Co., Ltd.4
Sun Yat-sen University4
Wuhan Sian Medical Technology Co., Ltd4
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd3
The First Affiliated Hospital of Soochow University3
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology3
Chinese PLA General Hospital2
First Affiliated Hospital Xi'an Jiaotong University2
Fujian Medical University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma73
Leukemia, Lymphocytic, Chronic, B-Cell9
Lymphoma, B-Cell9
Recurrence8
Leukemia6
Lymphoma, Non-Hodgkin6
Leukemia, Myeloid, Acute4
Lymphoma4
Leukemia, Prolymphocytic, B-Cell3
Lymphoma, Follicular3

Trials

Showing 1 to 25 of 73. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.